Terms ending in 2027
Every in-force patent on Biogen MA Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,228,015 | Nogo Receptor Antagonists and Methods of Increasing Neurite Outgrowth In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| US 10,328,125 | Treatments for Neurological Disorders In force · High confidence | Sinfonia Biotherapeutics AB | In force | High confidence | |
| US 10,233,245 | Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab In force · Low confidence | Biogen MA Inc. | In force | Low confidence | |
| US 11,292,845 | Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab In force · Medium confidence | Biogen MA Inc. | In force | Medium confidence | |
| US 10,466,251 | Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| US 11,333,670 | Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| US 12,607,638 | Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| US 9,493,567 | Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab In force · Medium confidence | Biogen MA Inc. | In force | Medium confidence | |
| US 8,883,462 | Triprenyl Phenol Compound, Process for Production of Triprenyl Phenol Compound, and Thrombolysis Enhancer In force · High confidence | Corxel Pharmaceuticals Hong Kong Limited | In force | High confidence | |
| US 8,992,924 | Anti-Alpha V Beta 6 Antibodies and Uses Thereof In force · High confidence | Biogen MA Inc. | In force | High confidence | |
| 9 more term ends in 2027 · Pro | |||||
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19, all of them expiring within the 18 months from Nov 22, 2026.
16 of these are in force and held by Biogen MA Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.